Latin America Osteoporosis Drugs Market Size & Outlook
The osteoporosis drugs market in Latin America is expected to reach a projected revenue of US$ 653.2 million by 2030. A compound annual growth rate of 2.4% is expected of Latin America osteoporosis drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$551.9
Forecast, 2030 (US$M)
$653.2
CAGR, 2024 - 2030
2.4%
Report Coverage
Latin America
Latin America osteoporosis drugs market, 2018-2030 (US$M)
Latin America osteoporosis drugs market highlights
- The Latin America osteoporosis drugs market generated a revenue of USD 551.9 million in 2023.
- The market is expected to grow at a CAGR of 2.4% from 2024 to 2030.
- In terms of segment, branded was the largest revenue generating product in 2023.
- Branded is the most lucrative product segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2023 | USD 551.9 million |
| Market revenue in 2030 | USD 653.2 million |
| Growth rate | 2.4% (CAGR from 2023 to 2030) |
| Largest segment | Branded |
| Fastest growing segment | Branded |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Branded |
| Key market players worldwide | Amgen Inc, Eli Lilly and Co, Merck & Co Inc, Novartis AG ADR, Pfizer Inc, GlaxoSmithKline, Radius Health, UCB SA, Teva Pharmaceutical Industries Ltd, Roche Holding AG |
Other key industry trends
- In terms of revenue, Latin America region accounted for 3.7% of the global osteoporosis drugs market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,641.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Osteoporosis Drugs Market Scope
Osteoporosis drugs market segmentation & scope
Type
Bisphosphonates
Parathyroid Hormone Therapy
Calcitonin
Selective Estrogen Inhibitors Modulator
Rank Ligand Inhibitors
Other
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Osteoporosis Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
